Importantly, once female patients are treated with high‐dose melphalan and autologous stem‐cell transplantation, female sex predicts a good outcome in patients who respond to therapy.36 Although not statistically significant, TIMP‐1 level showed a tendency to be a predictor in cardiac amyloidosis. This evidence concerns the gene TIMP1 and cardiac amyloidosis.